Type
Ji. Rifampicin resistant leprosy: a review and a research proposal of a pilot study. Leprosy review [Internet]. 2002;73(1):2-8. Available from: https://leprosyreview.org/article/73/1/00-0002
Type
Darier J. [Tuberculosis, leprosy, syphilis and cancer research--trends of development. 1935]. Orvosi hetilap. 2002;143(10):515-7.
Type
Geluk A, Meijgaarden K, Franken K, Subronto Y, Wieles B, Arend S, et al. Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis. Infection and immunity [Internet]. 2002;70(5):2544-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC127910/pdf/1187.pdf
Type
Guilloton, Drouet, Combemale, Cruel, Dupin, Ribot. [Neuritic leprosy disclosed by reversal reaction]. Revue neurologique. 2002;158(1):84-6.
Type
Meyer TN, Thoma, Fawcett, Ginty, Veltry. Decompression of the common peroneal nerve: experience with 20 consecutive cases. Plastic and reconstructive surgery. 2002;109(5):1755-6; author reply 1756.
Type
Ffytche. Lettsomian Lecture. Hansen's warning. Transactions of the Medical Society of London. 1999;116:72-6.
Type
Helene LMF, Salum MJL. [Social reproduction of leprosy: a study of patients profile with leprosy in the city of São Paulo]. Cadernos de saude publica [Internet]. 2002;18(1):101-13. Available from: http://www.scielo.br/pdf/csp/v18n1/8147.pdf
Type
Mustafa, Bjune, Jonsson, Pando, Nilsen. Increased expression of fas ligand in human tuberculosis and leprosy lesions: a potential novel mechanism of immune evasion in mycobacterial infection. Scandinavian journal of immunology. 2001;54(6):630-9.
Type
Sharma. Keratitis. Bioscience reports. 2001;21(4):419-44.
Type
Desikan. A comparative trial of single-dose chemotherapy in paucibacillary leprosy patients with two to three skin lesions. Indian journal of leprosy. 2001;73(4):364-6; author reply 366-7.